Using FDA Law to Threaten Medical Practice | New England Journal of Medicine www.nejm.org/doi/full/10.... The expert authors (Lewis Grossman, @nathancortez.bsky.social & @pzettler.bsky.social) explain why this is troubling and may have implications far beyond the treatment of gender-affirming care.
Using FDA Law to Threaten Medical Practice | NEJM
Though recent subpoenas from the U.S. DOJ target providers of gender-affirming care, the legal arguments behind them could affect physicians prescribing off-label treatment for any reason.
nejm.org